Last reviewed · How we verify
Zuragard (isopropanol)
At a glance
| Generic name | isopropanol |
|---|---|
| Drug class | isopropanol |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Antiseptic preparation
Common side effects
Key clinical trials
- CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (NA)
- Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process (NA)
- Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation (PHASE2)
- HEMA-free Universal Adhesives for Restoring Non-carious Cervical Lesions (NA)
- Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation (PHASE2)
- Effect of Ice Pack and Warm Gel Pad Use During Drain Removal on Anxiety, Comfort, Physiological Parameters, and Patient Satisfaction Undergoing Open Urological Surgery (NA)
- Randomized Controlled Trial of Vaginal Cryotherapy for Pelvic Floor Myofascial Pain (NA)
- VCOM Pain Free Research Collaborative (NA)
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zuragard CI brief — competitive landscape report
- Zuragard updates RSS · CI watch RSS
- portfolio CI